Dr Harding on the Rationale for Targeting FGFR2 in Cholangiocarcinoma and Biliary Tract Cancer Published 2023-05-17 Download video MP4 360p Download video MP4 720p Recommendations 24:03 Medical Stories - Bile Duct Cancer: Stephanie's Story 1:06:14 Cholangiocarcinoma 44:47 Starving cancer cells without starving YOU - With Dr. Siddhartha Mukherjee 06:11 Newly Diagnosed: Bile Duct Cancer 05:36 Gallbladder Polyps; When To Remove Gallbladder? 26:10 How I Learned I had Pancreatic Cancer: My First Signs - Roger | The Patient Story 06:31 Understanding Cholangiocarcinoma 12:43 Lung Cancer Surgery 22:35 Conquer IBS: 3 steps to healthier digestion 10:40 Esophageal Cancer Signs & Symptoms (& Why They Occur) 37:02 What more can you do to treat pulmonary fibrosis (if already on medication)? 00:59 What is a choledochal cyst? 08:37 Cancer Metastasis in the Liver - All Symptoms 05:15 What happens during and after a colonoscopy? 09:34 Hilar Cholangiocarcinoma Explained: Dr. Thomas Fishbein 02:01 FGFR Mutations 08:58 Primary Sclerosing Cholangitis: Visual Explanation for Students 02:25 Bile Duct Cancer: A patient's journey 06:06 Colon Cancer: Don't Ignore Your Symptoms Similar videos 04:51 Natural history of patients with advanced CCA with FGFR2 gene alterations or wild-type FGFR2 00:39 Discover how the FGFR2 gene influences cell behaviour and its link to cancer when mutated. #FGFR2 01:30 FGFR2 06:00 FGFR Inhibitor Toxicity Profile 49:48 ICRN Webinar: "What is IDH1 mutated cholangiocarcinoma and what else can we do for it?” 1:18:56 AC20 - Different Modalities for Profiling 1:02:48 Harnessing the Power of Immunotherapy in HCC and BTC: The Past, Present, and Future 00:32 OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2 | RTCL.TV 1:12:26 WATCH NOW: Harnessing the Power of Immunotherapy in HCC and BTC 53:34 Translational Dysequilibrium at the Bedside-Bench Interface More results